BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Ulcerative Colitis

Below is an extended Ulcerative Colitis research listing. Click here to return to the Ulcerative Colitis main in depth entry.

Recent Publications on Ulcerative Colitis:

Once-daily versus three-times-daily mesalazine granules in active ulcerative colitis: A double-blind, double-dummy, randomised non-inferiority trial.
OBJECTIVES: To determine the therapeutic equivalence and safety of once...
Direct Link
4th October, 2008
Germany.
Date of birth in the occurrence of inflammatory bowel disease.
Background: It has been speculated that prenatal or perinatal exposure to...
Direct Link
4th October, 2008
Portland VA Medical Center and Oregon Health & Science University,
Prebiotics in chronic intestinal inflammation.
Prebiotics are nondigestible fermentable fibers that are reported to have...
Direct Link
4th October, 2008
Centre of Excellence for Gastrointestinal Inflammation and Immunity
[Effect of Bawei Xilei powder on CD3, CD4, CD8 T-lymphocytes of rats with ulcerative colitis] 4th October, 2008
Jiangxi University of Traditional Chinese Medicine, Nanchang 330006,
Increased expression of the tight junction molecule claudin-18 A1 in both experimental colitis and ulcerative colitis.
Background: We previously identified a major quantitative trait locus...
Direct Link
3rd October, 2008
Department of Gastroenterology, Vrije Universiteit Medical Center,
Alterations of peripheral blood CD5(+) B cells in inflammatory bowel disease.
Objective. CD5(+) B cells comprise a unique subset of B cells that...
Direct Link
3rd October, 2008
Department of Internal Medicine II, Shimane University School of Medicine,
Is exercise beneficial to the inflammatory bowel diseases? An implication of heat shock proteins.
Inflammatory bowel diseases (IBD) cause the intestines to become inflamed...
Direct Link
3rd October, 2008
School of Kinesiology, Faculty of Health Sciences, University of Western
Effect of the Polymorphism of Tumor Necrosis Factor-alpha-308 G/A Gene Promoter on the Susceptibility to Ulcerative Colitis: A Meta-Analysis.
Background: Ulcerative colitis (UC) is a complex polygenic disease in...
Direct Link
2nd October, 2008
Department of Gastroenterology, First Affiliated Hospital of Nanjing
Local application of tacrolimus in distal colitis: Feasible and safe.
Background: Tacrolimus is a potent immunomodulator that is effective in...
Direct Link
1st October, 2008
Department of Gastroenterology & Hepatology, Erasmus MC, University
Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease.
Background: CBir1 is a dominant antigen with a role in innate and adaptive...
Direct Link
1st October, 2008
Inflammatory Bowel Disease Research Center, Cedars-Sinai Medical Center,
Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.
Objective. Recent findings indicate that bacteria play an important role...
Direct Link
1st October, 2008
Department of Gastroenterology and Hematology, Graduate School of Medicine
High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease.
Vitamin K and D deficiency and decreased bone mineral density (BMD) were...
Direct Link
1st October, 2008
Department of Food and Nutrition, Kyoto Women's University, 35,
Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
BACKGROUND: Crohn's disease (CD) and ulcerative colitis (UC) have a...
Direct Link
1st October, 2008
Netherlands.
Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
Abstract Aim: To evaluate granulocytapheresis (GCAP) in active ulcerative...
Direct Link
1st October, 2008
U.O. di Gastroenterologia, Azienda Ospedaliera-Universitaria Pisana, Pisa,
[Effect of retention enema with combination of compound glutamine entero-soluble capsule and glucocorticoids for treatment of ulcerative colitis] 1st October, 2008
Department of Gastroenterology, People's Hospital of Tianjin, Tianjin.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional